塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/10/06 | 1,134 | 1,142 | 1,123 | 1,125 | -2 | -0.2% | 2,269,900 |
2011/10/05 | 1,137 | 1,145 | 1,121 | 1,127 | -7 | -0.6% | 1,958,500 |
2011/10/04 | 1,130 | 1,138 | 1,125 | 1,134 | +3 | +0.3% | 1,952,200 |
2011/10/03 | 1,138 | 1,141 | 1,125 | 1,131 | -22 | -1.9% | 2,043,800 |
2011/09/30 | 1,149 | 1,158 | 1,148 | 1,153 | +4 | +0.3% | 2,410,100 |
2011/09/29 | 1,143 | 1,151 | 1,137 | 1,149 | -1 | -0.1% | 1,594,400 |
2011/09/28 | 1,144 | 1,158 | 1,141 | 1,150 | -6 | -0.5% | 1,330,600 |
2011/09/27 | 1,157 | 1,162 | 1,147 | 1,156 | +10 | +0.9% | 1,710,200 |
2011/09/26 | 1,162 | 1,179 | 1,141 | 1,146 | -7 | -0.6% | 1,568,600 |
2011/09/22 | 1,156 | 1,158 | 1,145 | 1,153 | -15 | -1.3% | 1,812,400 |
2011/09/21 | 1,173 | 1,180 | 1,166 | 1,168 | +1 | +0.1% | 607,300 |
2011/09/20 | 1,170 | 1,178 | 1,163 | 1,167 | -7 | -0.6% | 826,600 |
2011/09/16 | 1,178 | 1,185 | 1,168 | 1,174 | +15 | +1.3% | 1,373,700 |
2011/09/15 | 1,158 | 1,163 | 1,152 | 1,159 | +19 | +1.7% | 1,747,400 |
2011/09/14 | 1,147 | 1,159 | 1,140 | 1,140 | -12 | -1% | 1,327,100 |
2011/09/13 | 1,150 | 1,163 | 1,146 | 1,152 | +7 | +0.6% | 1,710,900 |
2011/09/12 | 1,151 | 1,156 | 1,143 | 1,145 | -30 | -2.6% | 1,449,600 |
2011/09/09 | 1,174 | 1,185 | 1,172 | 1,175 | -11 | -0.9% | 4,214,100 |
2011/09/08 | 1,190 | 1,196 | 1,181 | 1,186 | +4 | +0.3% | 1,437,700 |
2011/09/07 | 1,183 | 1,188 | 1,172 | 1,182 | +9 | +0.8% | 1,394,300 |
2011/09/06 | 1,190 | 1,199 | 1,173 | 1,173 | -17 | -1.4% | 1,595,100 |
2011/09/05 | 1,201 | 1,205 | 1,186 | 1,190 | -18 | -1.5% | 1,546,100 |
2011/09/02 | 1,208 | 1,216 | 1,202 | 1,208 | -9 | -0.7% | 1,609,200 |
2011/09/01 | 1,230 | 1,241 | 1,214 | 1,217 | -12 | -1% | 1,344,200 |
2011/08/31 | 1,220 | 1,230 | 1,215 | 1,229 | +15 | +1.2% | 1,484,500 |
2011/08/30 | 1,233 | 1,234 | 1,214 | 1,214 | -10 | -0.8% | 1,925,200 |
2011/08/29 | 1,224 | 1,230 | 1,214 | 1,224 | +1 | +0.1% | 867,800 |
2011/08/26 | 1,220 | 1,229 | 1,216 | 1,223 | +4 | +0.3% | 983,500 |
2011/08/25 | 1,241 | 1,247 | 1,217 | 1,219 | -9 | -0.7% | 983,300 |
2011/08/24 | 1,263 | 1,265 | 1,224 | 1,228 | -31 | -2.5% | 1,415,600 |
2011/08/23 | 1,248 | 1,267 | 1,241 | 1,259 | +26 | +2.1% | 1,673,000 |
2011/08/22 | 1,217 | 1,239 | 1,213 | 1,233 | +14 | +1.1% | 1,400,600 |
2011/08/19 | 1,214 | 1,234 | 1,208 | 1,219 | -25 | -2% | 1,239,100 |
2011/08/18 | 1,219 | 1,248 | 1,216 | 1,244 | +18 | +1.5% | 1,212,000 |
2011/08/17 | 1,211 | 1,229 | 1,211 | 1,226 | ±0 | ±0% | 872,400 |
2011/08/16 | 1,232 | 1,239 | 1,218 | 1,226 | -13 | -1% | 1,046,900 |
2011/08/15 | 1,246 | 1,252 | 1,227 | 1,239 | +7 | +0.6% | 890,200 |
2011/08/12 | 1,233 | 1,239 | 1,215 | 1,232 | +1 | +0.1% | 1,534,800 |
2011/08/11 | 1,208 | 1,231 | 1,195 | 1,231 | +6 | +0.5% | 1,056,100 |
2011/08/10 | 1,225 | 1,231 | 1,211 | 1,225 | +23 | +1.9% | 1,152,200 |
2011/08/09 | 1,193 | 1,206 | 1,181 | 1,202 | -34 | -2.8% | 1,937,200 |
2011/08/08 | 1,230 | 1,241 | 1,224 | 1,236 | -11 | -0.9% | 1,533,700 |
2011/08/05 | 1,250 | 1,251 | 1,230 | 1,247 | -35 | -2.7% | 1,695,200 |
2011/08/04 | 1,282 | 1,300 | 1,279 | 1,282 | ±0 | ±0% | 1,449,800 |
2011/08/03 | 1,308 | 1,309 | 1,278 | 1,282 | -25 | -1.9% | 1,748,900 |
2011/08/02 | 1,320 | 1,321 | 1,291 | 1,307 | -35 | -2.6% | 2,811,500 |
2011/08/01 | 1,327 | 1,375 | 1,327 | 1,342 | +10 | +0.8% | 1,051,000 |
2011/07/29 | 1,344 | 1,353 | 1,331 | 1,332 | -18 | -1.3% | 985,600 |
2011/07/28 | 1,367 | 1,367 | 1,346 | 1,350 | -26 | -1.9% | 616,500 |
2011/07/27 | 1,378 | 1,383 | 1,370 | 1,376 | -7 | -0.5% | 736,800 |
3301~
3350
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 233,400円 | +5.7% | +3.9% | 2.46% | 11.61倍 | 1.54倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 760,400円 | +2.2% | +10.2% | 1.58% | 14.64倍 | 1.47倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 139,000円 | +18.5% | -96.0% | 5.32% | 177.75倍 | 1.63倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
協和キリン | 220,400円 | -3.5% | -11.3% | 2.72% | 20.24倍 | 1.36倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
エーザイ | 394,200円 | +1.7% | -2.9% | 4.06% | 25.86倍 | 1.36倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム